课题基金 / 基金详情

Development and application of a non-rejectable islet graft using Indolamine 2,3-dioxygenase, in non-obese diabetic mouse.

Development and application of a non-rejectable islet graft using Indolamine 2,3-dioxygenase, in non-obese diabetic mouse.
使用吲哚胺 2,3-双加氧酶在非肥胖糖尿病小鼠中开发和应用不可排斥的胰岛移植物。
批准号：
197341
负责人：
Hosseini-Tabatabaei Azadeh
金额：
$10.93万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-11-01 至 2012-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=197341&lang=en
关键词：
3 Dioxygenase Gene Transfer Indolamine 2 Local Immunosuppression Non-Rejectable Islet Engraftment Non-Viral Vectors Pancreatic Islets Isolation Pancreatic Islets Transplantation Type 1 Diabetes Mellitus

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes is a chronic disease causing long-term problems in patients' kidneys, eyes, nerves and almost all other organs. Studies have shown that about 2.2 million people are suffering from diabetes in Canada. Unfortunately, 3.8 million people in the world
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金